Physician profile
Rafael Alvarez
NPI 1487090858
$2,726.95
in general payments reported to CMS, 2019-2025
8 companies · $142 in 2025
The $142 reported for 2025 was less than what a typical Obesity Medicine (Preventive Medicine) provider received nationally (typical 2025 total: $203).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $107 · 2022: $178 · 2023: $1,374 · 2024: $926 · 2025: $142.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,384 · Travel and Lodging: $1,010 · Gift: $34.34 · Education: $12.98.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,384.24 |
| Travel and Lodging | $1,010.43 |
| Gift | $34.34 |
| Education | $12.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,261.04 | 2023-2024 | Da Vinci Surgical System |
| Reshape Lifesciences INC. | $134.05 | 2022 | |
| Conmed Corporation | $90.91 | 2021 | |
| Merit Medical Systems INC | $69.69 | 2025 | Esophyx |
| Novo Nordisk INC | $57.09 | 2024-2025 | Wegovy |
| Boston Scientific Corporation | $54.17 | 2025 | Spyglass Discover |
| W. L. Gore & Associates, INC. | $43.90 | 2022 | |
| Endo Pharmaceuticals INC. | $16.10 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Rafael Alvarez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.